A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer

NCT06974929 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: HRS-6209 Capsules
DRUG: Letrozole Tablets
DRUG: HRS-2189 Tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.